About Us

Novocure is a global, commercial-stage oncology business with operations in the United States, Europe and Asia.

Novocure (NASDAQ: NVCR) is an oncology company pioneering a novel therapy for solid tumors called Tumor Treating Fields, or TTFields. Headquartered in Jersey Isle, Novocure’s US operations are based in Portsmouth, NH and New York, NY. Additionally, the company has offices in Switzerland, Germany and Japan and a research center in Haifa, Israel.

Our History

Novocure is an overnight success story fourteen years in the making. Since 2000, the company has grown from one inspired man running experiments in his basement lab to the multinational commercial business it is today.

View the Corporate Timeline

Media Kit

Whether you need specific information to write a story or just want to learn more about Novocure, this section provides quick access to information about our company.

Learn more here

Our Leadership

Novocure is managed by a team of senior leaders with extensive experience across the oncology, biotechnology and medical device industries.

Meet our Executives

Delivered by Investis (opens in a new window)